Navigation Links
New compound holds high promise in battling kidney cancer
Date:2/19/2013

ing bacterium Pseudomonas syringae. TIR-199 is a synthetic relative of syringolin.

"At UCR we began to work on, and completed the synthesis of, two compounds from this class of compounds," Pirrung said. "Of the two, TIR-199 showed most promise."

Pirrung's lab first shipped TIR-199 samples to the University of Hawaii, Hilo, where Andr Bachmann, an associate professor of pharmaceutical sciences and Pirrung's collaborator, studied TIR-199 in test-tube assays for how it worked against the proteasome. Bachmann then tested the compound against a limited number of cancer cell lines that showed that TIR-199 was effective against the cancer cells. What remained unclear, however, was if TIR-199 was toxic to normal cells.

Encouraged by these results, Pirrung submitted TIR-199 samples to the National Cancer Institute at the National Institutes of Health, where the compound was subjected to a rigorous 60-cell screening used routinely to test compounds for their effectiveness in battling 60 kinds of cancer, including leukemia, lung, colon, brain, breast, ovarian prostate and renal cancers.

"We were very excited when the NCI informed us that TIR-199 has excellent potential to be moved to drug development because of its selective activity against renal cancer," Pirrung said. "This is good news also because the NCI scientists told us there really are no good drugs out there to fight renal cancer."

Next, the NCI will test TIR-199 on cells grown in a hollow fiber that partially mimics the body by offering a three-dimensional environment. If the test results are positive, TIR-199 will be tested on mice.

The UCR Office of Technology Commercialization has
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Red wine, fruit compound could help block fat cell formation
2. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
3. Biosynthetic grape-derived compound prevents progression of Alzheimers disease in mice
4. Could Compound in Artificial Sweeteners Worsen Crohns Disease?
5. Natural Sciences Repository Publishes Chromatography and Acidic Compounds Resources
6. Breast-Milk Compound May Shield Babies From HIV
7. Red wine compound could help seniors walk away from mobility problems
8. Green tea compound shows promise for tackling cancer
9. Compounds activate key cancer enzyme to interfere with tumor formation
10. Second Compounding Pharmacy Shut Down in Massachusetts
11. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New compound holds high promise in battling kidney cancer
(Date:8/1/2014)... Summer is here, and with it comes the season ... they can be a pain for dogs. Animal Emergency & ... customers get rid of ticks and prevent them completely. , ... summer, which is why they are so active during this ... areas and carry a number of diseases, including lyme disease, ...
(Date:8/1/2014)... August 01, 2014 As AndroGel lawsuits ... country, Ronald E. Johnson, Jr. has been appointed as ... and other testosterone medications. Since the Fall of 2013, ... have worked diligently to investigate and prosecute the claims ... and blood clots as a result of taking testosterone. ...
(Date:8/1/2014)... benefits of a cancer diagnosis may improve health outcomes ... conducted by a researcher at the University of Houston ... writing intervention is the writing instruction. Otherwise, writing is ... a journal can be therapeutic, but oftentimes we don,t ... or not," said Qian Lu, assistant professor and director ...
(Date:8/1/2014)... 01, 2014 Growing prevalence of ... healthcare reforms are boosting healthcare market growth, although ... discounts and increasing generic consumption is a major ... million in 2013, having grown at a Compound ... The implementation of the Health Transformation Program (Saglikta ...
(Date:8/1/2014)... Hawley, PA (PRWEB) August 01, 2014 Hot ... in the destination spa category of the World’s Best ... kicks off a month-long celebration of National Relaxation Day (technically ... together a series of MAJOR experts to help guests celebrate ... how important it is for health and wellness to carve ...
Breaking Medicine News(10 mins):Health News:Tis the Season for Tick Prevention 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 2Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 3Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 4
... traffic pollution may increase respiratory problems and reduce lung ... studied the effects of road and traffic density on ... town of Ciudad Juarez in Mexico. , Our results ... at home or at school, can lead to chronic ...
... 13 The owners of five,separate Miami-based health ... Assistant Attorney General Alice S. Fisher of the ... the Southern District of,Florida announced today. Collectively, the ... $28.6 million worth of unnecessary durable,medical equipment (DME) ...
... Inc. (Nasdaq: ISIS ) announced today that ... orphan drug status to ISIS 333611 for,the treatment ... (ALS),commonly referred to as Lou Gehrig,s disease. ALS ... of muscle control that can,lead to death. ISIS ...
... part of NDA submission in 2009, SYDNEY, Australia, ... of a second Phase III clinical trial for its,lead ... placebo controlled, double blind safety extension trial is,designed to ... the,Company,s submission of a New Drug Application (NDA) to ...
... 13 This year, pack nutrients,into your holiday ... sponsored by Dairy Council of California.,Instead of ... serve lightened-up holiday classics like Candy Cane Cocoa, ... and the bone-building benefits,of calcium, a much-needed nutrient ...
... Mass. and NEW YORK, Dec. 13 Boston,Scientific ... Partners, a leading,private equity firm, today jointly announced ... will acquire from Boston Scientific its Fluid,Management and ... The,transaction is expected to close in the first ...
Cached Medicine News:Health News:Heavy traffic makes breathing a burden in children 2Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 2Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 3Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 4Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 2Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 3Health News:QRxPharma Initiates Second Phase III Clinical Trial for its 'Dual Opioid' Pain Therapy 2Health News:Seasonal Sippers Supply Bone-Building Benefits 2Health News:Seasonal Sippers Supply Bone-Building Benefits 3Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 2Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 3Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 4Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 5
(Date:8/1/2014)... -- Research and Markets  has announced the ... Markets (Lab-Based, Professional POC, Home, Employment, Criminal Justice ... http://photos.prnewswire.com/prnh/20130307/600769 Drugs ... IVD testing with competitive participation by top IVD ... justice personnel, and sports use drug tests as ...
(Date:8/1/2014)... 2014 RoundTable Healthcare Partners ("RoundTable"), an ... healthcare industry, announced today the sale of Vesta ... Lubrizol, a Berkshire Hathaway company, is a specialty ... customers in the global transportation, industrial and consumer ... Vesta is an ISO-13485 certified medical ...
(Date:8/1/2014)... According to the new ... Anti infective), Basic (Films, Cleansing), Advanced (Hydrogels, Hydrocolloids, ... Pressure Relief Devices, NPWT) - Global Forecast to ... is expected to reach $18.3 Billion by 2019 ... CAGR of 3.2% from 2014 to 2019. ...
Breaking Medicine Technology:Drugs of Abuse Testing Markets (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets) 2RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation 2Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
No. 1. 30 mm conventional blades. Thin well-rounded tips....
Aspirating adjustable lid speculum is ideal for cataract and laser refractive procedures....
Open 15 mm blades with lifting wings manipulation of I/A cannulas, knives, instrumentation, etc. Screwlocking mechanism. Dull finish....
Solid 8 mm blades. Dull finish. Most popular size or model....
Medicine Products: